Two of the most popular compounds for boosting growth hormone sit on opposite sides of a fundamental divide. CJC-1295 is an injectable GHRH analog that amplifies your body’s natural GH pulses. MK-677 is an oral ghrelin-receptor agonist you swallow like a vitamin. Both raise GH and IGF-1, but they get there through completely different pathways - and that distinction shapes everything from side effects to who should use which.
Quick Comparison
| Feature | CJC-1295 | MK-677 (Ibutamoren) |
|---|---|---|
| Primary Mechanism | GHRH receptor agonist | Ghrelin receptor agonist |
| Typical Dosing | 100-300 mcg injected 2-3x/day (no DAC) or 2 mg/week (with DAC) | 10-25 mg orally once daily |
| Route of Administration | Subcutaneous injection | Oral |
| FDA Status | Research compound, not FDA approved | Research compound, not FDA approved |
| Best For | Targeted, pulsatile GH elevation with fewer metabolic side effects | Convenient daily GH/IGF-1 elevation without needles |
| Approximate Cost | $40-80/month | $30-60/month |
| Common Side Effects | Injection-site irritation, flushing, headache | Increased appetite, water retention, elevated blood glucose |
| Half-Life | ~30 min (no DAC) / ~8 days (with DAC) | ~4.7 hours [1] |
What Is CJC-1295?
CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), the endogenous signal your hypothalamus sends to the pituitary gland telling it to produce and release GH. The peptide was developed to overcome the extremely short half-life of native GHRH (which degrades in under 10 minutes in circulation) by modifying the amino acid sequence to resist enzymatic breakdown.
Two versions exist and they behave very differently. CJC-1295 without DAC - often sold as Modified GRF (1-29) - has a half-life of roughly 30 minutes and produces sharp, defined GH pulses that mimic natural physiology. CJC-1295 with DAC (Drug Affinity Complex) binds to albumin in the blood, extending its half-life to approximately 8 days and creating a sustained, elevated GH baseline rather than distinct pulses.
The “no DAC” version is far more popular in performance and anti-aging circles because pulsatile GH release is considered more physiologically favorable. Constant GH elevation - what you get with the DAC variant - can desensitize GH receptors over time and carries a side-effect profile closer to exogenous GH itself. Most protocols pair CJC-1295 (no DAC) with a GHRP like Ipamorelin to synergistically amplify GH output.
What Is MK-677 (Ibutamoren)?
MK-677 is a growth hormone secretagogue and ghrelin receptor agonist that increases endogenous GH and IGF-1 secretion [2]. Developed in 1995 and later studied by Merck for GH deficiency, it stands out because it is orally bioavailable and does not require injections [3]. Despite frequently being lumped in with SARMs by supplement retailers, MK-677 acts on the ghrelin receptor, not the androgen receptor - it is pharmacologically distinct from SARMs entirely [4].
The ghrelin pathway is what makes MK-677 unique and also what makes it tricky. Ghrelin is your body’s hunger hormone, so activating that receptor does far more than just raise GH. It spikes appetite, can elevate blood glucose and cortisol, and causes notable water retention [5]. Users commonly report gaining 10-20 pounds of water weight in the first few weeks before the bloat stabilizes and actual lean tissue accrual becomes apparent [6].
Clinical research has explored MK-677 for treating growth hormone deficiencies, sarcopenia, osteoporosis, and muscle-wasting diseases, with trials showing increases in bone mineral density, lean body mass, and IGF-1 levels in elderly and postmenopausal populations [7]. It is banned in drug-tested competition [8].
Key Differences Between CJC-1295 and MK-677
Mechanism of Action: Two Different Doors Into the Same Room
This is the most important distinction. CJC-1295 works through the GHRH pathway - it tells the pituitary to produce more growth hormone by mimicking the hypothalamic signal. MK-677 works through the ghrelin pathway - it mimics the hunger hormone to trigger GH release from a completely separate receptor system [3].
Why does this matter practically? The ghrelin pathway carries metabolic baggage. When you activate the ghrelin receptor, you get GH release but you also get appetite stimulation, potential blood glucose elevation, and cortisol bumps [5]. CJC-1295 sidesteps all of this because GHRH receptors don’t regulate appetite or glucose metabolism. If you are insulin-resistant, pre-diabetic, or trying to stay lean during a cut, CJC-1295 is the dramatically cleaner option.
GH Release Pattern
CJC-1295 without DAC produces discrete GH pulses - a spike that rises and falls within a couple of hours. This mimics healthy endogenous GH secretion and is generally considered safer for long-term use because the pituitary gets recovery time between pulses.
MK-677 creates a more sustained elevation. While its half-life is only 4.7 hours [1], the downstream effect on IGF-1 lasts the full 24-hour dosing window. Clinical studies typically use 25 mg per day, and dosing above that threshold shows diminishing returns [1]. This sustained elevation is convenient but may blunt the pituitary’s sensitivity to GH-releasing signals over extended use.
Administration and Compliance
This is where MK-677 wins decisively. You swallow a capsule once a day. No reconstitution, no bacteriostatic water, no insulin syringes, no refrigeration. For people who travel frequently, dislike needles, or simply want the lowest-friction protocol possible, MK-677 is the obvious choice.
CJC-1295 requires subcutaneous injection, typically in the abdominal fat. The no-DAC version needs 2-3 injections per day for optimal pulsatile release, which is a meaningful compliance burden. The DAC version requires only 1-2 injections per week but trades pulsatile release for sustained elevation, which most practitioners consider suboptimal.
Side Effect Profiles
CJC-1295’s side effects tend to be mild and localized: injection-site redness, occasional flushing or warmth after injection, and mild headaches during the first week. Systemic side effects are uncommon at standard doses.
MK-677 hits harder metabolically. The appetite increase is substantial - not subtle hunger, but the kind that has people eating a second dinner at midnight. Water retention is pronounced, especially early on [6]. Blood glucose elevation is clinically documented and can push borderline individuals into pre-diabetic ranges [5]. It should be dosed away from bedtime to limit sleep disruption [5], though some users report improved sleep quality from the GH surge - responses vary.
Cost and Accessibility
Both compounds exist in a gray market of research chemical vendors and compounding pharmacies. MK-677 is generally cheaper ($30-60/month) and easier to source because it is a small molecule that is simple to manufacture and ship as a capsule or liquid. CJC-1295 runs $40-80/month depending on the vendor and whether you factor in supplies (syringes, bacteriostatic water, alcohol swabs). The cost gap is modest, but MK-677’s oral format eliminates the ancillary supply costs.
CJC-1295 vs MK-677: Which Should You Choose?
Choose CJC-1295 if: - You prioritize a clean side-effect profile over convenience. No appetite spikes, no water bloat, no glucose disruption. - You are cutting or recomping and cannot afford the appetite increase or water retention MK-677 causes. - You have any degree of insulin resistance or blood sugar concerns. The ghrelin pathway is the wrong lever to pull if glucose management is already an issue. - You are comfortable with injections and willing to maintain a 2-3x daily protocol (or pair with a GHRP for once-daily dosing). - You want the most physiologically natural GH release pattern with pulsatile spikes and clear troughs.
Choose MK-677 if: - Convenience is your top priority. One capsule daily, no injection supplies, no cold chain. - You are in a bulking phase and the increased appetite is a feature, not a bug. Hardgainers who struggle to eat enough actually benefit from ghrelin-receptor activation. - You want sustained IGF-1 elevation for recovery, sleep quality, and connective tissue repair. - You are healthy with no blood sugar concerns and can manage the water retention through sodium control and patience. - Budget is tight and you want the lowest total cost of entry into GH optimization.
For women specifically, MK-677 is typically not recommended due to the water retention effects [6]. CJC-1295 at conservative doses (100 mcg 1-2x daily, often paired with Ipamorelin) tends to be better tolerated.
Can You Stack CJC-1295 and MK-677?
Yes, and it is one of the more popular GH-optimization stacks - but it requires thought. Because CJC-1295 and MK-677 work through entirely different receptor systems (GHRH vs ghrelin), they produce a synergistic effect that can elevate GH output beyond what either compound achieves alone. This is the same principle behind pairing a GHRH with a GHRP, except MK-677 replaces the injectable GHRP with an oral alternative.
A common protocol: CJC-1295 (no DAC) at 100 mcg injected before bed, with MK-677 at 10-15 mg taken in the morning. Splitting the timing reduces the chance of receptor desensitization and lets you capture the appetite effects of MK-677 during waking hours while the CJC pulse enhances your nocturnal GH surge.
The trade-off is that stacking means you inherit the side effects of both compounds. You get MK-677’s appetite and water retention on top of CJC-1295’s injection burden. For most recreational users, choosing one or the other based on the decision framework above makes more sense than stacking. The stack is better suited for experienced users who have already run each compound solo, understand their individual response, and have a specific reason to push GH output higher.
One important note: neither compound suppresses natural GH production through negative feedback in the way exogenous GH does. Both work by stimulating your own pituitary, so recovery after discontinuation is straightforward. That said, prolonged use of either (6+ months continuous) may reduce pituitary sensitivity, so cycling - 8-12 weeks on, 4 weeks off - is standard practice.
Read the Full Guide(s)
References
- MPMD - MK-677 Dosage and Administration (https://www.youtube.com/watch?v=Nng8T-bPdaU)
- MPMD - What is MK-677 (Ibutamoren)? (https://www.youtube.com/watch?v=Nng8T-bPdaU)
- Ryan Russo - Mechanism of Action of MK-677 (Ibutamoren) (https://www.youtube.com/watch?v=sXGHc22fPOM)
- Elite Athlete - MK-677 is Not a SARM (https://www.youtube.com/watch?v=cBgkPynoMBA)
- MPMD - MK-677 Pharmacology and Misconceptions (https://www.youtube.com/watch?v=VVPZRucd-bQ)
- Dr. Gabrielle Lyon - MK-677 for Muscle Mass (https://www.youtube.com/watch?v=073WMTTRzO8)
- MPMD - Clinical Applications of MK-677 (https://www.youtube.com/watch?v=Nng8T-bPdaU)
- Greg Doucette - What Is MK-677 and How Does It Work? (https://www.youtube.com/watch?v=6Dkva6GHvNM)